Impact of SGLT2 inhibitors on the outcomes of patients with cardiac arrhythmias and transthyretin cardiac amyloidosis

Heart Rhythm. 2024 Sep 6:S1547-5271(24)03292-2. doi: 10.1016/j.hrthm.2024.09.002. Online ahead of print.

Authors

Aravinthasamy Sivamurugan¹, Stefano H Byer², Udhayvir S Grewal³, Paari Dominic⁴

Affiliations

¹ Carver College of Medicine, University of Iowa, Iowa City, Iowa.
² Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
³ Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
⁴ Division of Cardiology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa. Electronic address: [email protected].

PMID: 39245251
DOI: 10.1016/j.hrthm.2024.09.002

No abstract available

Keywords: ATTR cardiac amyloidosis; Cardiac arrhythmias; Cardiomyopathy; SGLT2 inhibitors.